Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Copine-4 (CPNE4) is a member of the copine family, which are highly conserved, calcium-dependent membrane-binding proteins characterized by their tandem C2 domains and a von Willebrand factor type A (VWA) domain[2]. Copine-4 is predominantly expressed in the brain, especially in retinal ganglion cells and excitatory neurons, and functions as a calcium sensor involved in transient plasma membrane association, cytoskeletal interactions, and protein–protein binding[1][2][3]. It regulates neuronal morphology and differentiation, is linked with endolysosomal pathways and synaptic processes, and may participate in cellular responses related to neurodevelopment and neurodegeneration, such as Alzheimer’s disease[1][2]. Though not currently considered a direct therapeutic target or receptor, evidence implicates Copine-4 in several brain disorders and cancer[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copine-4 (CPNE4).